Study to Assess the Safety and Effectiveness of the Penumbra System

Completed

Phase 2 Results

Summary of Purpose

This clinical evaluation is a prospective, single-arm, multi-center trial. The purpose of this clinical evaluation is to assess the safety and effectiveness of the Penumbra System in the revascularization of patients presenting with acute ischemic stroke secondary to intracranial, large vessel, occlusive disease.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 January 2009.

1 Jun 2006 2 Jun 2006 1 Jun 2007 1 Nov 2007 1 Dec 2008 20 Nov 2008
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

  • Jim Pray President Penumbra, Inc. 2401 Merced St., Ste. 200 San Leandro, CA 94577 Telephone: 510-618-3299 Fax: 510-618-3232

    jpray@penumbrainc.com